Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Times Interest Earned (2016 - 2025)

Ocular Therapeutix has reported Times Interest Earned over the past 13 years, most recently at -$24.63 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$24.63 for Q4 2025, down 51.28% from a year ago — trailing twelve months through Dec 2025 was -$22.82 (down 80.34% YoY), and the annual figure for FY2025 was -$22.82, down 80.32%.
  • Times Interest Earned for Q4 2025 was -$24.63 at Ocular Therapeutix, down from -$22.88 in the prior quarter.
  • Over the last five years, Times Interest Earned for OCUL hit a ceiling of -$4.83 in Q4 2023 and a floor of -$24.63 in Q4 2025.
  • Median Times Interest Earned over the past 5 years was -$12.02 (2022), compared with a mean of -$13.42.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 53.92% in 2023 and later tumbled 237.12% in 2024.
  • Ocular Therapeutix's Times Interest Earned stood at -$10.74 in 2021, then grew by 2.43% to -$10.48 in 2022, then skyrocketed by 53.92% to -$4.83 in 2023, then crashed by 237.12% to -$16.28 in 2024, then crashed by 51.28% to -$24.63 in 2025.
  • The last three reported values for Times Interest Earned were -$24.63 (Q4 2025), -$22.88 (Q3 2025), and -$22.43 (Q2 2025) per Business Quant data.